JPRN-UMIN000027058已完成未知
sefulness of kestose for the patients with NAFLD and NASH - Treatment with kestose for NAFLD/NASH
agoya University Hospital0 个研究点目标入组 60 人开始时间: 2017年4月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Women with pregnancy or possible pregnancy 2.Patients with severe renal failure and heart failure 3.Patient who is considered to be inappropriate for entry into the trial by the investigator 4.Medical doctors decided the patients are inappropriate. 5.Patients with substantial alcohol consumption (20g/day for women or >30g/day for men). 6.Patients with poor glycemic control (HbA1c>9.0%) 7.Patients with other active hepatitis and hepatocellular carcinoma 8.Patients with history of gastrointestinal surgery 9.Patients who take nonabsorbable antibiotic
研究者
相似试验
招募中
不适用
sefulness of kestose for the patients with NAFLD and NASHJPRN-jRCTs041180162Honda Takashi60
招募中
1 期
Evaluation of the effectness of kestose in unresectable pancreatic cancerunresectable pancreatic cancerJPRN-jRCTs041200109Hirooka Yoshiki40
已完成
2 期
Ketohexokinase Inhibition in NAFLDNAFLDNCT05463575Maastricht University Medical Center15
招募中
不适用
Efficacy and safety of lacosamide in patients with erythromelalgia due to SCN9A gene mutatioerythromelalgiaJPRN-UMIN000028778niversity of the Ryukyus Hospital1
招募中
2 期
Efficacy and safety of lacosamide in patients with erythromelalgia due to SCN9A gene mutatioFamilial erythromelalgiaJPRN-jRCTs071180055Takahashi Kenzo6